These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 20407456)

  • 1. Arguments against precompetitive collaboration.
    Vargas G; Boutouyrie B; Ostrowitzki S; Santarelli L
    Clin Pharmacol Ther; 2010 May; 87(5):527-9. PubMed ID: 20407456
    [No Abstract]   [Full Text] [Related]  

  • 2. Open-minded to open innovation and precompetitive collaboration.
    Wagner JA
    Clin Pharmacol Ther; 2010 May; 87(5):511-5. PubMed ID: 20407451
    [No Abstract]   [Full Text] [Related]  

  • 3. The Biomarkers Consortium: practice and pitfalls of open-source precompetitive collaboration.
    Wagner JA; Prince M; Wright EC; Ennis MM; Kochan J; Nunez DJ; Schneider B; Wang MD; Chen Y; Ghosh S; Musser BJ; Vassileva MT
    Clin Pharmacol Ther; 2010 May; 87(5):539-42. PubMed ID: 20407460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How informatics can potentiate precompetitive open-source collaboration to jump-start drug discovery and development.
    Perakslis ED; Van Dam J; Szalma S
    Clin Pharmacol Ther; 2010 May; 87(5):614-6. PubMed ID: 20376001
    [No Abstract]   [Full Text] [Related]  

  • 5. The Critical Path Institute's approach to precompetitive sharing and advancing regulatory science.
    Woosley RL; Myers RT; Goodsaid F
    Clin Pharmacol Ther; 2010 May; 87(5):530-3. PubMed ID: 20407457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Precompetitive research: a new prescription for drug development?
    Woodcock J
    Clin Pharmacol Ther; 2010 May; 87(5):521-3. PubMed ID: 20407454
    [No Abstract]   [Full Text] [Related]  

  • 7. Precompetitive activity to address the biological data needs of drug discovery.
    Sidders B; Brockel C; Gutteridge A; Harland L; Jansen PG; McEwen R; Michalovich D; Seidel H; Weiss B; Williams-Jones B; Woodwark M
    Nat Rev Drug Discov; 2014 Feb; 13(2):83-4. PubMed ID: 24481293
    [No Abstract]   [Full Text] [Related]  

  • 8. New IGF drug stirs competition in growth factor segment.
    Ratner M
    Nat Biotechnol; 2005 Oct; 23(10):1192. PubMed ID: 16211044
    [No Abstract]   [Full Text] [Related]  

  • 9. Market watch: Biopharma deal-making in 2014: a record year for M&A value.
    Micklus A; Muntner S
    Nat Rev Drug Discov; 2015 Feb; 14(2):84-5. PubMed ID: 25633786
    [No Abstract]   [Full Text] [Related]  

  • 10. Indian generics companies go on spending spree.
    Jayaraman KS
    Nat Rev Drug Discov; 2005 Aug; 4(8):616-7. PubMed ID: 16106583
    [No Abstract]   [Full Text] [Related]  

  • 11. Deal watch: recent trends in deal-making.
    Dawkes A; Papp T
    Nat Rev Drug Discov; 2010 Dec; 9(12):909. PubMed ID: 21119724
    [No Abstract]   [Full Text] [Related]  

  • 12. Europe fiddles while innovation burns.
    Frantz S
    Nat Rev Drug Discov; 2005 Sep; 4(9):704-5. PubMed ID: 16178115
    [No Abstract]   [Full Text] [Related]  

  • 13. Small molecule challenges dominance of TNF-alpha inhibitors.
    Sheridan C
    Nat Biotechnol; 2008 Feb; 26(2):143-4. PubMed ID: 18259158
    [No Abstract]   [Full Text] [Related]  

  • 14. Vertical integration: the drug industry and prescription benefits managers.
    Gibaldi M
    Pharmacotherapy; 1995; 15(3):265-71. PubMed ID: 7667161
    [No Abstract]   [Full Text] [Related]  

  • 15. Research & market strategy: how choice of drug discovery approach can affect market position.
    Sams-Dodd F
    Drug Discov Today; 2007 Apr; 12(7-8):314-8. PubMed ID: 17395091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biotech jostles with pharma for slice of HIV market.
    Katsnelson A
    Nat Biotechnol; 2006 Jan; 24(1):3-4. PubMed ID: 16404375
    [No Abstract]   [Full Text] [Related]  

  • 17. Bye, bye blockbusters, hello niche busters.
    Collier R
    CMAJ; 2011 Aug; 183(11):E697-8. PubMed ID: 21690224
    [No Abstract]   [Full Text] [Related]  

  • 18. The future is much closer collaboration between the pharmaceutical industry and academic medical centers.
    Vallance P; Williams P; Dollery C
    Clin Pharmacol Ther; 2010 May; 87(5):525-7. PubMed ID: 20407455
    [No Abstract]   [Full Text] [Related]  

  • 19. Collaboration may be the cure for what ails drug development.
    Erickson AK
    Nat Med; 2004 Jun; 10(6):558. PubMed ID: 15170189
    [No Abstract]   [Full Text] [Related]  

  • 20. The evolving role of collaboration in biotechnology.
    Gower JM
    Nat Biotechnol; 1998 May; 16 Suppl():31-2. PubMed ID: 9591261
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.